identified variants at the PCSK9 locus associated with reductions in LDL-c and demonstrated that lower LDL-c results in higher body weight, WHR, fasting plasma glucose, HbA1c, and liability to type 2 diabetes.75 This evidence concerns the gene PCSK9 and type 2 diabetes mellitus.